Hikma And Adalvo Ally On Nasal Spray For MENA

Licensing Deal For ‘High-Value’ Product Follows Hikma’s US Ryaltris Launch

 
• By David Wallace
  
Nasal spray nose
Hikma has licensed an allergic rhinitis treatment from Adalvo in the MENA region • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business